Calgary-developed wound treatment used on the battlefield in Ukraine

Calgary-based NanoTess has developed an innovative wound treatment called NanoSALV, initially funded by Canada's Department of National Defence. The treatment, which consists of a lightweight, non-flammable gel, has been approved by Health Canada and is now being delivered by drone to wounded soldiers and civilians in war-torn Ukraine.

The NanoSALV catalyst, suspended in the gel, works with the body's natural healing process, speeding up recovery and fighting infection-causing micro-organisms. Since its deployment in Ukraine in June, the treatment has been used to treat 6,000 wounded individuals. The treatment's effectiveness is particularly crucial in military settings, as it allows for quick application by individuals with limited medical training, reducing the strain on medical resources.